Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
Allarity Therapeutics Inc
ALLR
Healthcare
Biotechnology
Allarity Therapeutics, Inc., a clinical-stage precision medicine pharmaceutical company, focuses on developing novel anti-cancer therapeutics for patients with unmet medical needs. The company develops drugs for the personalized treatment of cancer using drug specific companion diagnostics generated by its proprietary drug response predictor technology. Its lead drug candidate includes...
Stenoparib, a novel dual inhibitor of poly-ADP-ribose polymerase (PARP1/2) that is being evaluated in a phase 2 clinical trial in patients with advanced and recurrent ovarian cancer. The company also develops stenoparib- DRP, a companion diagnostic product used in select patients for stenoparib treatment. Allarity Therapeutics, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (NDAQ:ALLR)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
Next
(714)
•••
Iseneschal
X
Comment by
Iseneschal
on Oct 09, 2025 12:16pm
RE:ALLR ....better than a poke in the eye with a sharp stick
Trading this a.m at $1.77 and starting to gain some traction just broke the RBL trend line....On watch for continuation
(714)
•••
Iseneschal
X
Post by
Iseneschal
on Oct 06, 2025 2:20pm
ALLR ....better than a poke in the eye with a sharp stick
$1.68
(714)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 24, 2025 3:34pm
ALLR....started a position this afternoon
$1.61 Cheers !
(714)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 22, 2025 12:04pm
ALLR....ALLR....ALLR
ALLR....AH AH Lay !!!! I love u
(714)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 22, 2025 11:25am
ALLR.....sold all into the a.m strength to H.O.D
I'll be back because the News is good Cheers !
(714)
•••
Iseneschal
X
Comment by
Iseneschal
on Sep 22, 2025 10:39am
RE:New Press Release - Allarity Therapeutics Presents New Phase 2 Clinical Data for Stenoparib/2X-121 Showing Landmark Median Overall Survival Has Now Surpassed 25 Months
ALLR is trending higher on this a.m's NR....currently trading over $1.80....the sh price has broken thru the DTL and the next target would be a break of $1.93......Fingers crossed for a new All
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on Sep 22, 2025 8:00am
New Press Release - Allarity Therapeutics Presents New Phase 2 Clinical Data for Stenoparib/2X-121 Showing Landmark Median Overall Survival Has Now Surpassed 25 Months
- Kaplan-Meier analyses show for the first time that median Overall Survival exceeds 25 months for Platinum Resistant and Refractory Ovarian Cancer Patients receiving stenoparib/2X-121 twice daily- Two patients continue on therapy now more than 24 months - Clinical Benefit Evident in...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Sep 17, 2025 8:00am
New Press Release - Allarity Therapeutics CEO to Present at Biomarkers & Precision Medicine 2025
TARPON SPRINGS, Fla., September 17, 2025 – Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib—a differentiated, dual PARP and WNT pathway inhibitor—today announced that its CEO, Thomas Jensen...
read article.
(714)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 12, 2025 3:24pm
ALLR....Can u jerk that offer any louder Mr. M
Ur a joke
(714)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 12, 2025 3:14pm
ALLR...N.L.O.D....$1.70
Whack the bid Mr. Maggot!!!! Happy Fryday
(714)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 12, 2025 3:12pm
ALLR....N.L.O.D $1.71
Just started a small position Happy Fryday
(714)
•••
Iseneschal
X
Comment by
Iseneschal
on Sep 12, 2025 2:54pm
RE:ALLR....just broke $1.93 support
JUst tapped $1.74 and broke the RBL....just might go quite a bit lower ; ) Happy Fryday
(714)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 08, 2025 1:03pm
ALLR....just broke $1.93 support
$1.70 here we come.....don't quit ur day job just yet ; ) Today is just not my day
(714)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 08, 2025 11:52am
ALLR....On watch !! over $2.02...possible breakout
needs to hold support at $1.93.....and would like to see a break of previous high when the NR was announced... Here is the old news : Allarity Therapeutics Granted FDA Fast Track Designation for
...more
(714)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 08, 2025 11:33am
ALLR.....over $2.00 this a.m on decent volume
This kind of looks like Mr. M is "Walkin the Dog" The Trend is your friend....and the previous News was extremely positive
Prev
1
2
3
4
5
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Featured News Links
A custom portable drill advancing exploration in Labrador
A clean tech company on the verge of transformational growth plans to uplist to major US exchange
Vertical integration could reshape this scaling beverage brand’s long-term outlook
A transformational year in 2025 and positive outlook for growth in revenue and profitability in 2026
Podcasts